Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800.
This new 900-page five-country market intelligence and technology assessment report from Venture Planning Group will help current suppliers and potential market entrants identify and evaluate emerging opportunities and develop effective strategic responses. The report explores future trends in major European countries (France, Germany, Italy, Spain, UK); provides estimates of the specimen, test and sales volumes, as well as major suppliers sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.
The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. However, this evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.
Table of Contents
II. Worldwide Technology and Market Overview
A. Major Routine Chemistry Tests
B. Therapeutic Drug Monitoring (TDM)
C. Endocrine Function Tests
D. Tumor Markers and Special Chemistry Tests
E. Immunoprotein Tests
F. Drug of Abuse
G. Instrumentation Review: Operating characteriscs
and features of high-, medium-, and low-volume/POC
H. Major In Vitro Diagnostic Technologies
and Their Potential Applications
III. FranceIV. Germany
VI. SpainVII. U.K.
VIII. Major Product Development Opportunities
IX. Design Criteria for Decentralized Testing Products
X. Alternative Market Penetration Strategies
XI. Potential Market Entry Barriers and Risks
Contains 900 pages and 335 tables
SIMILAR MARKET STUDIES
About This ReportThis new 322-page report from VPGMarketResearch.com presents detailed analysis of the French Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.In addition ...
February 2017 | $0 | View Details >>
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “Future Horizons and Growth Strategies in the French Clinical Chemistry and Immunodiagnostics Market 2015” is a new strategic analysis of major business opportunities emerging in the French clinical chemistry and immunodiagnostic markets during the next five years. The report explores future ...
June 2015 | $3950 | View Details >>
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising ...
June 2015 | $3500 | View Details >>
This new report from VPGMarketResearch.com provides analysis of Cyclosporin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices - Ambulatory ...
July 2016 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research